In order to evaluate the role of four biomarkers in NASH diagnosis, the nomogram containing four biomarkers (MRPL16, RPL35, RPS3A, and RPS8) was generated (Figure 4A), and the calibration curves proved that the performance of the prediction model was effective (Figure 4B). This evidence concerns the gene RPL35 and metabolic dysfunction-associated steatohepatitis.